Bitar Ahmad Naoras, Sulaiman Syed Azhar Syed, Ali Irfhan Ali Bin Hyder, Khan Amer Hayat
Department of Clinical Pharmacy, Universiti Sains Malaysia, Gelugore, Malaysia.
Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Jln Tun Hamdan Sheikh Tahir, Kepala Batas, Pulau Pinang, Malaysia.
J Adv Pharm Technol Res. 2021 Oct-Dec;12(4):395-401. doi: 10.4103/japtr.japtr_98_21. Epub 2021 Oct 20.
The link between chronic obstructive pulmonary disease (COPD) and osteoporosis is unclear and yet to be understood. The study goals were to detect the prevalence of osteoporosis and investigate its predictors among COPD patients. This is a longitudinal study conducted in a tertiary care setting. During the study, patients' bone mineral density was checked, pulmonary parameters were recorded, and a risk assessment tool was validated. Based on T-score, more than 50% of subjects were osteoporotic. Spirometric parameters were significantly lower among osteoporotic patients. For the risk assessment tool, a cutoff point of 34 made the optimum balance between sensitivity and specificity (0.867 and 0.087, respectively) with a generated area under the curve of 0.934. Severe COPD patients were four times at higher risk of getting osteoporosis, forced expiratory volume (FEV) % predicted, and FEV/forced vital capacity was inversely related to the risk of osteoporosis. Patients with severe dyspnea had twice the risk of getting osteoporosis. Osteoporosis was prevalent among COPD patients, and severe COPD patients were at higher risk of getting osteoporosis.
慢性阻塞性肺疾病(COPD)与骨质疏松症之间的联系尚不清楚,有待进一步了解。本研究的目的是检测骨质疏松症的患病率,并调查COPD患者中骨质疏松症的预测因素。这是一项在三级医疗环境中进行的纵向研究。在研究过程中,检查了患者的骨密度,记录了肺部参数,并验证了一种风险评估工具。根据T值,超过50%的受试者患有骨质疏松症。骨质疏松症患者的肺量计参数显著较低。对于风险评估工具,截断值为34时,在敏感性和特异性之间取得了最佳平衡(分别为0.867和0.087),曲线下面积为0.934。重度COPD患者患骨质疏松症的风险高出四倍,预计用力呼气量(FEV)%以及FEV/用力肺活量与骨质疏松症风险呈负相关。严重呼吸困难的患者患骨质疏松症的风险高出两倍。骨质疏松症在COPD患者中很普遍,重度COPD患者患骨质疏松症的风险更高。